- Report
- January 2026
- 370 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 559 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 369 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 477 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 382 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 287 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 479 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 471 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 379 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 366 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 280 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 371 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 340 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 182 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 291 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 462 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 461 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 566 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 475 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 375 Pages
Global
From €5217EUR$5,850USD£4,523GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more